We want to hear what matters most to patients when it comes to accessing medicines in Australia.
Your feedback will help us better understand patient experiences and priorities, and will help inform discussions between the Generic and Biosimilar Medicines Association (GBMA) and the Australian Government on future medicines policy.
By taking part, you can help make sure the patient voice is part of the conversation.
How your information will be used
The Generic and Biosimilar Medicines Association (GBMA) is conducting this survey to better understand patients’ experiences accessing prescription medicines in Australia. Participation is voluntary. Your responses will help inform GBMA’s policy and advocacy activities, including discussions with the Australian Government on future medicines policy and Strategic Agreements.
GBMA may analyse survey responses, prepare reports and submissions, and publish or share findings with government agencies, patient organisations, healthcare stakeholders, industry representatives and the broader public.
Survey findings will be reported in an aggregated or de-identified form. GBMA will take reasonable steps to protect your privacy and minimise the risk that individual respondents could be identified. Individual survey responses will not be shared in an identifiable form without your separate consent.
For more information about how GBMA collects, uses, stores and protects your personal information, please refer to our Privacy Policy